MetLife Investment Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,379
| Closed | -$169K | – | 2341 |
|
|
2020
Q4 | $169K | Hold |
13,379
| – | – | ﹤0.01% | 2069 |
|
|
2020
Q3 | $131K | Hold |
13,379
| – | – | ﹤0.01% | 2090 |
|
|
2020
Q2 | $133K | Hold |
13,379
| – | – | ﹤0.01% | 2119 |
|
|
2020
Q1 | $118K | Buy |
+13,379
| New | +$118K | ﹤0.01% | 1985 |
|
|
2019
Q4 | – | Sell |
-8,973
| Closed | -$52.8K | – | 2344 |
|
|
2019
Q3 | $52.8K | Hold |
8,973
| – | – | ﹤0.01% | 2324 |
|
|
2019
Q2 | $108K | Hold |
8,973
| – | – | ﹤0.01% | 2354 |
|
|
2019
Q1 | $108K | Hold |
8,973
| – | – | ﹤0.01% | 2293 |
|
|
2018
Q4 | $113K | Hold |
8,973
| – | – | ﹤0.01% | 2242 |
|
|
2018
Q3 | $133K | Hold |
8,973
| – | – | ﹤0.01% | 2311 |
|
|
2018
Q2 | $151K | Hold |
8,973
| – | – | ﹤0.01% | 2050 |
|
|
2018
Q1 | $205K | Hold |
8,973
| – | – | ﹤0.01% | 1878 |
|
|
2017
Q4 | $232K | Buy |
+8,973
| New | +$232K | ﹤0.01% | 1852 |
|